Alpha-GPC

Alpha-GPC, Alpha-glycerylphosphorylcholine, L-alpha-glycerophosphocholine, Glycerophosphocholine

Alpha-GPC is a choline-containing supplement that is found in a large variety of food products but can be pharmacology activated in high doses as well. Alpha-GPC supplementation increases acetylcholine and choline on the brain, influencing their systemic concentrations. Some athletes use Alpha-GPC due to its capacity for energy enhance before intense activities.

Nutraceutic

  • Origin Plant Based, Animal Product, Synthetic
  • Source Eggs, Wheat Germs, Soybean, Synthetic
  • Type Phospholipid, Nootropic

Cognitive Function and Brain Health

Cognitive functions are brain skills divided into: memory, perception, language, executive functions, attention and praxis (ability to perform complex movements). These functions depend on healthy synapses and neurons, which require good overall brain functioning. Supplements can affect cognitive function directly or indirectly. Direct effects can alter or participate in neurotransmissions and influence the brain's energy metabolism. The indirect effects include hormonal changes that affect the brain, and improvements in cognitive disorders such as anxiety, depression and insomnia.
  • Cognition

    Cognition refers to the mental processes involved in gaining knowledge and comprehension. Cognitive actions include thinking, knowing, remembering, judging, and problem-solving. These are higher-level functions of the brain and include language, imagination, perception, and planning.

Muscle Health

The muscles are responsible for body movement, stabilization, regulation of organs, substance transportation and production of heat in addition to being strongly associated with the circulatory and nervous systems. Muscle quality is essential for well being. Supplements that help keep muscles healthy are related to different factors, such as glucose and insulin regulation, protein synthesis, energy metabolism, and others.
  • Power Output

    Power output is the strength the body can develop in the shortest amount of time. It have to do with muscle fibers, creatine stores and ATP.
  • Age Range Adults (20-59)
  • Toxicity May be toxic in high doses
  • Side effects Headaches, Diarrhea, Lower Blood Pressure, Excessive Sweting, Fish Odor
  • Warnings

Why be Careful

References

  1. a b Hoffman JR, et al. The effects of acute and prolonged CRAM supplementation on reaction time and subjective measures of focus and alertness in healthy college studentsJ Int Soc Sports Nutr. (2010)
  2. a b c Di Perri R, et al. A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementiaJ Int Med Res. (1991)
  3. a b A neurotropic approach to the treatment of multi-infarct dementia using L-α-glycerylphosphorylcholine.
  4. a b Amenta F, et al. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer’s disease with cerebrovascular injury: interim resultsJ Neurol Sci. (2012)
  5. a b c d e f Tayebati SK, et al. Modulation of monoaminergic transporters by choline-containing phospholipids in rat brainCNS Neurol Disord Drug Targets. (2013)
  6. a b c d e Zeisel SH. Dietary choline: biochemistry, physiology, and pharmacologyAnnu Rev Nutr. (1981)
  7. a b c Scapicchio PL. Revisiting choline alphoscerate profile: a new, perspective, role in dementiaInt J Neurosci. (2013)
  8. a b c Zhang K, et al. Purification of L-alpha glycerylphosphorylcholine by column chromatographyJ Chromatogr A. (2012)
  9. a b c Armah CN, et al. L-alpha-glycerophosphocholine contributes to meat’s enhancement of nonheme iron absorptionJ Nutr. (2008)
  10. ^ SCHMIDT G, HERSHMAN B, THANNHAUSER SJ. The isolation of alpha-glycerylphosphorylcholine from incubated beef pancreas; its significance for the intermediary metabolism of lecithinJ Biol Chem. (1945)
  11. ^ Brockerhoff H, Yurkowski M. Simplified preparation of L-alpha-glyceryl phosphoryl cholineCan J Biochem. (1965)
  12. a b c d Brownawell AM, Carmines EL, Montesano F. Safety assessment of AGPC as a food ingredientFood Chem Toxicol. (2011)
  13. a b c d e f g h i j k l Concentrations of Choline-Containing Compounds and Betaine in Common Foods.
  14. ^ Gatti G, et al. A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteersInt J Clin Pharmacol Ther Toxicol. (1992)
  15. ^ Parnetti L, et al. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluationJ Neurol Sci. (2007)
  16. ^ Amenta F, et al. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmissionMech Ageing Dev. (2006)
  17. ^ Tayebati SK, et al. Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive ratsJ Neurol Sci. (2009)
  18. ^ Subbaiah PV, Ganguly J. Studies on the phospholipases of rat intestinal mucosaBiochem J. (1970)
  19. ^ Lecithinase and lysolecithinase of intestinal mucosa.
  20. ^ Absorption of lipids.
  21. ^ Parthasarathy S, Subbaiah PV, Ganguly J. The mechanism of intestinal absorption of phosphatidylcholine in ratsBiochem J. (1974)
  22. ^ ENZYME: 3.1.4.2.
  23. ^ The transphosphatidylation activity of phospholipase D.
  24. ^ Le Kim D, Betzing H. Intestinal absorption of polyunsaturated phosphatidylcholine in the ratHoppe Seylers Z Physiol Chem. (1976)
  25. ^ Subbaiah PV, Ganguly J. Transesterification of lysolecithin in the intestinal mucosa of ratsIndian J Biochem. (1971)
  26. a b c d Kawamura T, et al. Glycerophosphocholine enhances growth hormone secretion and fat oxidation in young adultsNutrition. (2012)
  27. a b Tayebati SK, Amenta F. Choline-containing phospholipids: relevance to brain functional pathwaysClin Chem Lab Med. (2013)
  28. ^ Klein J, et al. Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brainNeurochem Int. (1993)
  29. ^ Klein J. Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipidsJ Neural Transm. (2000)
  30. a b Abbiati G, et al. Absorption, tissue distribution and excretion of radiolabelled compounds in rats after administration of {14C}-L-alpha-glycerylphosphorylcholineEur J Drug Metab Pharmacokinet. (1993)
  31. a b c Trabucchi M, Govoni S, Battaini F. Changes in the interaction between CNS cholinergic and dopaminergic neurons induced by L-alpha-glycerylphosphorylcholine, a cholinomimetic drugFarmaco Sci. (1986)
  32. a b c d e f Sigala S, et al. L-alpha-glycerylphosphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the ratEur J Pharmacol. (1992)
  33. ^ Aleppo G, et al. Chronic L-alpha-glyceryl-phosphoryl-choline increases inositol phosphate formation in brain slices and neuronal culturesPharmacol Toxicol. (1994)
  34. a b c Schettini G, et al. Molecular mechanisms mediating the effects of L-alpha-glycerylphosphorylcholine, a new cognition-enhancing drug, on behavioral and biochemical parameters in young and aged ratsPharmacol Biochem Behav. (1992)
  35. a b c Lopez CM, et al. Effect of a new cognition enhancer, alpha-glycerylphosphorylcholine, on scopolamine-induced amnesia and brain acetylcholinePharmacol Biochem Behav. (1991)
  36. a b c Tayebati SK, et al. Effect of choline-containing phospholipids on brain cholinergic transporters in the ratJ Neurol Sci. (2011)
  37. ^ Tomassoni D, et al. Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive ratsCurr Alzheimer Res. (2012)
  38. ^ Canal N, et al. Effect of L-alpha-glyceryl-phosphorylcholine on amnesia caused by scopolamineInt J Clin Pharmacol Ther Toxicol. (1991)
  39. a b c Ferraro L, et al. Evidence for an in vivo and in vitro modulation of endogenous cortical GABA release by alpha-glycerylphosphorylcholineNeurochem Res. (1996)
  40. ^ Noradrenergic modulation of cortical acetylcholine release is both direct and gamma-aminobutyric acid-mediated.
  41. ^ Beani L, et al. Inversion of the alpha-2 and alpha-1 noradrenergic control of the cortical release of acetylcholine and gamma-aminobutyric acid in morphine-tolerant guinea pigsJ Pharmacol Exp Ther. (1988)
  42. ^ Nelson TJ, et al. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repairEur J Pharmacol. (2008)
  43. ^ Glanzman DL. PKM and the maintenance of memoryF1000 Biol Rep. (2013)
  44. ^ Ren SQ, et al. PKCλ is critical in AMPA receptor phosphorylation and synaptic incorporation during LTPEMBO J. (2013)
  45. a b Govoni S, et al. PKC translocation in rat brain cortex is promoted in vivo and in vitro by alpha-glycerylphosphorylcholine, a cognition-enhancing drugAnn N Y Acad Sci. (1993)
  46. a b c Lucchi L, et al. Cognition stimulating drugs modulate protein kinase C activity in cerebral cortex and hippocampus of adult ratsLife Sci. (1993)
  47. ^ Wang QJ. PKD at the crossroads of DAG and PKC signalingTrends Pharmacol Sci. (2006)
  48. a b Govoni S, et al. Protein kinase C increase in rat brain cortical membranes may be promoted by cognition enhancing drugsLife Sci. (1992)
  49. a b Nitsch R, et al. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer’s diseaseAnn N Y Acad Sci. (1991)
  50. ^ Wurtman RJ. Choline metabolism as a basis for the selective vulnerability of cholinergic neuronsTrends Neurosci. (1992)
  51. ^ Wurtman RJ, Blusztajn JK, Maire JC. “Autocannibalism” of choline-containing membrane phospholipids in the pathogenesis of Alzheimer’s disease-A hypothesisNeurochem Int. (1985)
  52. ^ Walter A, et al. Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patientsNeurobiol Aging. (2004)
  53. ^ Yang X, et al. Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidityJ Lipid Res. (2010)
  54. ^ Gentile MT, et al. Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer’s disease pathogenesisMol Neurobiol. (2012)
  55. ^ Milanesi L, et al. Direct three-dimensional visualization of membrane disruption by amyloid fibrilsProc Natl Acad Sci U S A. (2012)
  56. ^ De Jesus Moreno Moreno M. Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trialClin Ther. (2003)
  57. a b c Parnetti L, Amenta F, Gallai V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical dataMech Ageing Dev. (2001)
  58. ^ Parnetti L, et al. Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer’s typeDrugs Aging. (1993)
  59. ^ Barbagallo Sangiorgi G, et al. alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trialAnn N Y Acad Sci. (1994)
  60. a b c Alpha-GPC and power output; growth hormone.
  61. a b Ceda GP, et al. alpha-Glycerylphosphorylcholine administration increases the GH responses to GHRH of young and elderly subjectsHorm Metab Res. (1992)
  62. a b Agarwal N, et al. Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4TBipolar Disord. (2010)
  63. a b Babb SM, et al. Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy studyPsychopharmacology (Berl). (2002)
  64. ^ Silveri MM, et al. Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopyNMR Biomed. (2008)
  65. ^ Hurrell RF, et al. Meat protein fractions enhance nonheme iron absorption in humansJ Nutr. (2006)
  66. ^ Conrad ME, Umbreit JN, Moore EG. Iron absorption and transportAm J Med Sci. (1999)
  67. ^ Troesch B, et al. Optimization of a phytase-containing micronutrient powder with low amounts of highly bioavailable iron for in-home fortification of complementary foodsAm J Clin Nutr. (2009)